Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2116051rdf:typepubmed:Citationlld:pubmed
pubmed-article:2116051lifeskim:mentionsumls-concept:C1135183lld:lifeskim
pubmed-article:2116051lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:2116051lifeskim:mentionsumls-concept:C0806987lld:lifeskim
pubmed-article:2116051lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:2116051lifeskim:mentionsumls-concept:C1515877lld:lifeskim
pubmed-article:2116051lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:2116051lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:2116051pubmed:issue2lld:pubmed
pubmed-article:2116051pubmed:dateCreated1990-9-6lld:pubmed
pubmed-article:2116051pubmed:abstractTextThe effect of recombinant porcine interferon-gamma (rPoIFN gamma) on in vitro production of interleukin 1 (IL-1) by porcine blood monocytes was studied. Three-day-old cultures of porcine adherent blood mononuclear cells were treated by doses of rPoIFN gamma for 3 or 6 days before lipopolysaccharide (LPS)-induction. While rPoIFN gamma alone had no effect, a combined treatment by rPoIFN gamma and LPS enhanced the IL-1 secretory potential of adherent mononuclear cells and, to a lesser extent, the level of cell-associated IL-1. The IL-1 activity was neutralized by anti porcine IL-1 alpha and beta antisera. These results demonstrate that rPoIFN gamma has immunomodulatory effects in vitro on porcine monokine production.lld:pubmed
pubmed-article:2116051pubmed:languageenglld:pubmed
pubmed-article:2116051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2116051pubmed:citationSubsetIMlld:pubmed
pubmed-article:2116051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2116051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2116051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2116051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2116051pubmed:statusMEDLINElld:pubmed
pubmed-article:2116051pubmed:monthJunlld:pubmed
pubmed-article:2116051pubmed:issn0165-2427lld:pubmed
pubmed-article:2116051pubmed:authorpubmed-author:CharletMMlld:pubmed
pubmed-article:2116051pubmed:authorpubmed-author:LavenantLLlld:pubmed
pubmed-article:2116051pubmed:authorpubmed-author:LaverneSSlld:pubmed
pubmed-article:2116051pubmed:issnTypePrintlld:pubmed
pubmed-article:2116051pubmed:volume25lld:pubmed
pubmed-article:2116051pubmed:ownerNLMlld:pubmed
pubmed-article:2116051pubmed:authorsCompleteYlld:pubmed
pubmed-article:2116051pubmed:pagination117-24lld:pubmed
pubmed-article:2116051pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:meshHeadingpubmed-meshheading:2116051-...lld:pubmed
pubmed-article:2116051pubmed:year1990lld:pubmed
pubmed-article:2116051pubmed:articleTitleRecombinant porcine interferon-gamma activates in vitro porcine adherent mononuclear cells to produce interleukin 1.lld:pubmed
pubmed-article:2116051pubmed:affiliationINRA, Station de Virologie et d'Immunologie Moléculaires, Jouy-en-Josas, France.lld:pubmed
pubmed-article:2116051pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2116051lld:pubmed